Queensland Numbered Acts

[Index] [Table] [Search] [Search this Act] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

PUBLIC HEALTH (MEDICINAL CANNABIS) ACT 2016 - SECT 26

Criteria for grant of clinical trial approval

26 Criteria for grant of clinical trial approval

(1) When considering an application for a clinical trial approval the chief executive may have regard to the following—
(a) whether the applicant is a suitable person to hold the approval;
(b) any approval required for the clinical trial under the Therapeutic Goods Act 1989 (Cwlth) ;
(c) whether the medicinal cannabis to which the approval will apply has, or will be, manufactured or imported in accordance with the applicable law of the Commonwealth;
(d) any other information in the application for the approval;
(e) any other matters the chief executive reasonably considers relevant to deciding the application.
(2) Without limiting subsection (1), the chief executive may grant a clinical trial approval only if the chief executive is satisfied—
(a) the applicant is a suitable person to hold the approval; and
(b) the medicinal cannabis to which the approval will apply has, or will be, manufactured or imported in accordance with the applicable law of the Commonwealth.



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback